Miyazaki, Japan

Kozo Tsunoda


Average Co-Inventor Count = 3.4

ph-index = 1


Location History:

  • Miyazaki, JA (1977)
  • Nobeoka, JP (1978)

Company Filing History:


Years Active: 1977-1978

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Kozo Tsunoda: Innovator in Antiviral and Anticarcinogenic Drug Development

Introduction

Kozo Tsunoda is a prominent inventor based in Miyazaki, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antiviral and anticarcinogenic drugs. With a total of 2 patents, Tsunoda's work is recognized for its innovative approaches to drug preparation.

Latest Patents

Tsunoda's latest patents include a process for preparing 8,2'-O-anhydropurine nucleosides. This process involves heating 2',3'-O-sulfinyl-8-oxypurine nucleosides in an aprotic polar solvent in the presence of an alkali metal, alkaline earth metal, or ammonium salt of an inorganic or organic weak acid. Another notable patent is for 2,3-O-sulfinyl-cytidine-5-phosphate, which details a method for preparing 2,2'-anhydrocytidine-5'-phosphate. This compound is known for its antitumor activity and is prepared by heating a novel intermediate in various solvents.

Career Highlights

Kozo Tsunoda is associated with Asahi Kasei Kogyo Kabushiki Kaisha, where he has been instrumental in advancing research and development in pharmaceutical applications. His innovative methods have paved the way for new treatments in the medical field.

Collaborations

Tsunoda has collaborated with notable coworkers such as Tsuneo Sowa and Kiyohide Sako. Their combined expertise has contributed to the success of various projects within their organization.

Conclusion

Kozo Tsunoda's contributions to the field of pharmaceuticals through his innovative patents highlight his role as a key inventor in the development of antiviral and anticarcinogenic drugs. His work continues to influence the industry and pave the way for future advancements.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…